FindTrial
Sign In

Fetal and maternal outcome in abruptio placenta

A prospective observational study of fetomaternal outcome of abruptio placenta - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/06/068493
Enrollment
30
Registered
2024-06-06
Start date
Unknown
Completion date
Unknown
Last updated
2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: 1- Obstetrics

Interventions

Intervention1: NIL: NIL

Sponsors

Dr Lirisha Vinodkumar Saxena
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All pregnant women diagnosed to have abruptio placenta from 28 weeks of gestation.

Exclusion criteria

Exclusion criteria: All pregnant women over 28 weeks of gestation who were admitted with Placenta previa, genital tract trauma, lesion of genital tract Vasa previa Uterine rupture Cervicitis Carcinoma

Design outcomes

Primary

MeasureTime frame
To assess maternal and perinatal outcome in the form of morbidity and mortalityTimepoint: 15 MONTHS—

Secondary

MeasureTime frame
To evaluate possible etiological factors of abruptio placenta Timepoint: 15 MONTHS—

Countries

India

Contacts

Public ContactDr. Dipti C. Parmar
kda2308@yahoo.com9925021608

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026